Uncategorized
Postmenopausal hormone medications may decrease POAG risk in women
Taking postmenopausal hormone medications containing estrogen may reduce women’s risk of developing primary open-angle glaucoma, according to a study.The study retrospectively analyzed 152,163 outpatient pharmacy claims of women age 50 years or older enrolled in a U.S. managed-care plan who had had at least two visits to an eye care provider in 4 years between 2001 and 2009 and received postmenopausal hormone medications. The medications contained estrogen only, estrogen and progesterone, or estrogen and androgen. Hazard ratios for developing incident POAG were determined for all eligible enrollees.